EarlyDiagnostics’ MethylScan™ Platform Validated in PNAS Study, Demonstrating Multi-Disease Detection from a Single Blood Sample

LOS ANGELES–(BUSINESS WIRE)– #Biotech–EarlyDiagnostics (EarlyDx) announced PNAS validation of its MethylScan™ platform for multi-disease detection from a single blood sample.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks